Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
19.03. | Sona Nanotech Inc.: Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model | 740 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - March 19, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to provide updated data confirming efficacy of its Targeted... ► Artikel lesen | |
06.03. | Sona Nanotech Inc. CEO David Regan to Present at the Investor Summit Virtual on March 11 | 371 | ACCESS Newswire | NEW YORK, NY / ACCESS Newswire / March 6, 2025 / David Regan, CEO of Sona Nanotech Inc. (OTCQB:SNANF)(CSE:SONA), will be presenting at this year's Investor Summit Virtual on March 11th at 11:30am ET.About... ► Artikel lesen | |
12.02. | Sona Nanotech Inc.: Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference | 416 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - February 12, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its recently published findings from its... ► Artikel lesen | |
14.01. | Sona Nanotech Inc: Sona publishes THT cancer therapy efficacy studies | 1 | Stockwatch | ||
13.01. | Sona Nanotech Inc.: Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal | 448 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - January 13, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that the now complete findings from our previously... ► Artikel lesen | |
SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
12.12.24 | Sona Nanotech Inc: Sona releases results from preclinical study of GNRs | 4 | Stockwatch | ||
11.12.24 | Sona Nanotech Inc.: Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study | 537 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - December 11, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted... ► Artikel lesen | |
07.11.24 | Sona Nanotech Inc.: Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update | 528 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - November 7, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its Chief Scientific Officer, Dr. Len Pagliaro... ► Artikel lesen | |
21.10.24 | Sona Nanotech Inc: Sona receives U.S. patent for gold nanorod process | 2 | Stockwatch | ||
21.10.24 | Sona Nanotech Inc.: Sona Nanotech Issued Patent and Appoints New Board Member | 551 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 21, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the issuance of U.S. Patent No. 12117447 by... ► Artikel lesen | |
09.10.24 | Sona Nanotech Inc: Sona Nanotech grants option to buy 25,000 shares | 1 | Stockwatch | ||
09.10.24 | Sona Nanotech Inc.: Sona Nanotech Grants Options | 557 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 9, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has granted 25,000 incentive stock... ► Artikel lesen | |
24.09.24 | Sona Nanotech Inc.: Sona Nanotech Closes Private Placement Financing to Raise $1,643,750 in Gross Proceeds | 745 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - September 24, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private... ► Artikel lesen | |
05.09.24 | Sona Nanotech Inc.: Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing | 837 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - September 5, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private... ► Artikel lesen | |
31.07.24 | Sona Nanotech Inc.: Sona Nanotech to Arrange Private Placement Financing | 715 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 31, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that it plans to raise up to $1,500,000 through... ► Artikel lesen | |
26.06.24 | Sona Nanotech Inc.: Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study | 746 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 26, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that a detailed biomarker analysis of the recently... ► Artikel lesen | |
20.06.24 | Sona Nanotech Inc.: Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer | 747 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 20, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that its targeted hyperthermia therapy ("THT")... ► Artikel lesen | |
21.05.24 | Sona Nanotech Inc.: Sona Appoints Chief Medical Officer and Files Provisional Conjugation Patent | 813 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 21, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to advise that it has appointed Dr. Carman Giacomantonio MD... ► Artikel lesen | |
29.04.24 | Sona Nanotech Inc.: Sona's Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model | 867 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - April 29, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") announces further results from the triple negative breast cancer murine... ► Artikel lesen | |
12.04.24 | Sona Nanotech Inc.: Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study | 761 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - April 12, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce further positive interim results from its study... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 23,000 | -2,34 % | EQS-News: Formycon AG: Formycon berichtet über erfolgreiches Geschäftsjahr 2024 mit starken operativen Fortschritten und kontinuierlichem Ausbau der Marktposition | EQS-News: Formycon AG
/ Schlagwort(e): Jahresbericht/Jahresergebnis
Formycon berichtet über erfolgreiches Geschäftsjahr 2024 mit starken operativen Fortschritten und kontinuierlichem... ► Artikel lesen | |
OBDUCAT | 0,070 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
NANOPHASE TECHNOLOGIES | - | - | NANOPHASE TECHNOLOGIES Corp - 10-K, Annual Report | ||
KOPIN | 0,916 | +2,86 % | Kopin Aktie: Frühling lässt auf sich warten! | Das Technologieunternehmen sichert sich wichtige US-Armeefinanzierung für XR-Displays und einen 14-Millionen-Dollar-Auftrag für Wärmebildsysteme trotz fallender Aktienkurse Die Kopin Corporation hat... ► Artikel lesen | |
VEECO INSTRUMENTS | 17,700 | -6,35 % | Veeco Instruments Inc.: Veeco Updates Fourth Quarter and Full Year 2024 Guidance | PLAINVIEW, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today has updated its financial guidance for the fourth quarter and full year 2024. We expect revenue for... ► Artikel lesen | |
GAUZY | 8,110 | 0,00 % | Gauzy Ltd. adds Second Production Shift in Europe to Meet Strong Global Demand; Releases Preliminary Third Quarter Revenue Range and Provides Fourth Quarter Guidance | TEL AVIV, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control solutions, today announced that it has added a... ► Artikel lesen | |
NANOVIRICIDES | 1,040 | -2,80 % | NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company | SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company")(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that... ► Artikel lesen | |
NVE | 57,50 | -1,71 % | Dividendenbekanntmachungen (03.02.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY BRANDS INC US00508Y1029 0,17 USD 0,1641 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,0289 EUR AON PLC IE00BLP1HW54 0... ► Artikel lesen | |
ONTO INNOVATION | 105,00 | -9,48 % | EQS-Media: LPKF Laser & Electronics SE: Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran | EQS-Media / 02.04.2025 / 09:00 CET/CEST
Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran
LPKF schließt sich dem Packaging Applications... ► Artikel lesen | |
DOTZ NANO | 0,035 | +2,94 % | DOTZ NANO LIMITED: Dotz Gabelli Conference Participation - Webinar | ||
ACACIA RESEARCH | 2,920 | -3,95 % | Acacia Research Reports Third Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today... ► Artikel lesen | |
ADVANCE ZINCTEK | 0,434 | -1,36 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
LEHNER INVESTMENTS | 0,028 | 0,00 % | EQS-News: LEHNER INVESTMENTS AG: Alpay Ece verstärkt den Vorstand | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Personalie
LEHNER INVESTMENTS AG: Alpay Ece verstärkt den Vorstand
25.11.2024 / 16:15 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
NANOFOCUS | 0,780 | -11,36 % | NanoFocus schließt Kapitalerhöhung ab | Die NanoFocus AG hat die beschlossene Kapitalerhöhung gegen Sach- und Bareinlagen durchgeführt. Insgesamt wurden 6.021.664 neue Aktien zu je 1,00 Euro ausgegeben. Davon gingen 4.276.884 Aktien an die... ► Artikel lesen | |
RIBER | 2,640 | -2,22 % | Riber: 2024 business growth in line with guidance | 2024 business growth in line with guidance Revenues up +5% to €41.2mOrder book at end-2024: €21.7m Bezons (France), January 29, 2025 - 8:00 am (CET) - RIBER, a global market leader for MBE equipment... ► Artikel lesen |